Oct 1, 2020

CBD News You Can Use: FDA’s Progress and Other Updates

Click for PDF


Cost is free, but registration is required.

Thursday, October 1, 2020
1:00 p.m. to 2:00 p.m. Eastern
12:00 p.m. to 1:00 p.m. Central
11:00 a.m. to 12:00 p.m. Mountain
10:00 a.m. to 11:00 a.m. Pacific

Please join us for a webinar where Seyfarth attorneys Tonya Esposito and Renée Appel will discuss the evolving regulatory landscape over cannabidiol (CBD). In this program, we will cover:

  • An overview of the distinction between cannabis, hemp, marijuana, and CBD
  • A look at FDA’s regulatory activity over the past year
  • The FDA and FTC’s 2020 enforcement activity and consumer driven litigation
  • Status of states’ regulation of CBD
  • CBD products in the marketplace
  • Federal legislation and lobbying activity related to CBD


Tonya M. Esposito, Partner, Seyfarth Shaw LLP

Renée B. Appel, Associate, Seyfarth Shaw LLP

If you have any questions, please contact Danielle Freeman at dfreeman@seyfarth.com and reference this event.

*CLE Credit for these webinars is approved in the following states: CA, IL, NJ and NY. CLE Credit is pending for GA, TX and VA. Credit will be applied for, but cannot be guaranteed, in all other eligible jurisdictions. Please note that in order to receive full credit for attending each webinar, the registrant must be present for the entire session.